Diagnostic Performance of Dynamic Contrast-Enhanced MRI and 18F-FDG PET/CT for Evaluation of Soft Tissue Tumors and Correlation with Pathology Parameters

Published:April 05, 2022DOI:

      Rationale and Objectives

      To assess the diagnostic performance of dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and fluorine-18-fluorodeoxyglucose (18F-FDG) positron-emission tomography/computed tomography (PET/CT) parameters in evaluating the biological behavior of soft tissue tumors.

      Materials and Methods

      We retrospectively analyzed DCE-MRI and 18F-FDG PET/CT parameters in 78 patients with pathology-confirmed soft tissue tumors. A total of 78 patients had undergone DCE-MRI examination, while 24 patients with malignant soft tissue tumor had undergone 18F-FDG PET/CT examination. Microvessel density (MVD) and the Ki-67 labeling index (LI) were detected using immunohistochemistry. Differences in parameters (Ktrans, Kep, Ve, MVD, and Ki-67 LI) between benign and malignant tumors were compared. Differences in parameters (Ktrans, Kep, Ve, MVD, and SUVmax) between high- and low-proliferation malignant tumors (grouped by Ki-67 LI) were compared. Correlation of the DCE-MRI and 18F-FDG PET/CT parameters with MVD and Ki-67 LI was analyzed.


      Only the Ktrans, Kep, MVD, and Ki-67 LI differed significantly between the benign and malignant soft tissue tumors (all p < 0.001). Only Kep (p = 0.033) and SUVmax (p = 0.001) differed significantly between high- and low-proliferation malignant soft tissue tumors. Ktrans, Kep, and SUVmax correlated positively with MVD (r = 0.805, 0.778, 0.730, respectively; all p < 0.001), and with Ki-67 LI (r = 0.721, 0.685, 0.655, respectively; all p < 0.001).


      DCE-MRI and 18F-FDG PET/CT parameters indicate soft tissue tumor biological behavior and can be used to differentiate between benign and malignant soft tissue tumors and between high- and low-proliferation malignant soft tissue tumors.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Academic Radiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Marzi S
        • Stefanetti L
        • Sperati F
        • et al.
        Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast-enhanced MRI of soft tissue tumors.
        NMR Biomed. 2016; 29: 6-14
        • Rodríguez-Alfonso B
        • Simó-Perdigó M
        • Orcajo Rincón J
        Functional imaging in soft tissue sarcomas: update of the indications for 18F-FDG-PET/CT.
        Rev Esp Med Nucl Imagen Mol. 2020; 39: 233-243
        • WHO Classification of Tumours Editorial Board
        Soft tissue and bone tumours, WHO classification of tumours.
        5th ed. IARC Press, Lyon, France2020
        • Nakamura T
        • Matsumine A
        • Matsubara T
        • et al.
        The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis.
        J Surg Oncol. 2011; 104: 771-775
        • Kolovich GG
        • Wooldridge AN
        • Christy JM
        • et al.
        A retrospective statistical analysis of high-grade soft tissue sarcomas.
        Med Oncol. 2012; 29: 1335-1344
        • Crombé A
        • Marcellin PJ
        • Buy X
        • et al.
        Soft-tissue sarcomas: assessment of MRI features correlating with histologic grade and patient outcome.
        Radiology. 2019; 291: 710-721
        • Li X
        • Wang Q
        • Dou Y
        • et al.
        Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?.
        Skeletal Radiol. 2020; 49: 1829-1838
        • Bian Y
        • Jin P
        • Wang Y
        • et al.
        Clinical applications of DSC-MRI parameters assess angiogenesis and differentiate malignant from benign soft tissue tumors in limbs.
        Acad Radiol. 2020; 27: 354-360
        • Choi YJ
        • Lee IS
        • Song YS
        • et al.
        Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
        J Magn Reson Imaging. 2019; 50: 798-809
        • Sambri A
        • Bianchi G
        • Longhi A
        • et al.
        The role of 18F-FDG PET/CT in soft tissue sarcoma.
        Nucl Med Commun. 2019; 40: 626-631
        • Wang P
        • Li H
        • Hu Y
        • et al.
        Relationship between ultrasound features and Ki-67 labeling index of soft tissue sarcoma.
        Front Oncol. 2021; 11687878
        • Lee JH
        • Yoon YC
        • Seo SW
        • et al.
        Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index.
        Eur Radiol. 2020; 30: 914-924
        • Hoos A
        • Stojadinovic A
        • Mastorides S
        • et al.
        High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas.
        Cancer. 2001; 92: 869-874
      1. QIBA. Profiles - QIBA Wiki. Available at: Accessed June 27, 2021.

        • Thomsen HS
        • Morcos SK
        • Almén T
        • et al.
        Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.
        Eur Radiol. 2013; 23: 307-318
        • Kanda T
        • Osawa M
        • Oba H
        • et al.
        High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration.
        Radiology. 2015; 275: 803-809
        • Younis MH
        • Abu-Hijleh HA
        • Aldahamsheh OO
        • et al.
        Meta-Analysis of the diagnostic accuracy of primary bone and soft tissue sarcomas by 18F-FDG-PET.
        Med Princ Pract. 2020; 29: 465-472
        • Weidner N.
        Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.
        Breast Cancer Res Treat. 1995; 36: 169-180
        • Holash J
        • Maisonpierre PC
        • Compton D
        • et al.
        Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
        Science. 1999; 284: 1994-1998
        • Hylton N
        Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
        J Clin Oncol. 2006; 24: 3293-3298
        • Nico B
        • Benagiano V
        • Mangieri D
        • et al.
        Evaluation of microvascular density in tumors: pro and contra.
        Histol Histopathol. 2008; 23: 601-607
        • Hasegawa T
        • Yamamoto S
        • Yokoyama R
        • et al.
        Prognostic significance of grading and staging systems using MIB-1 score in adult patients with soft tissue sarcoma of the extremities and trunk.
        Cancer. 2002; 95: 843-851
        • Hasegawa T
        • Yokoyama R
        • Lee YH
        • et al.
        Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
        Oncology. 2000; 58: 66-74
        • Khalifa F
        • Soliman A
        • El-Baz A
        • et al.
        Models and methods for analyzing DCE-MRI: a review.
        Med Phys. 2014; 41124301
        • Spinnato P
        • Kind M
        • Le Loarer F
        • et al.
        Soft tissue sarcomas: the role of quantitative MRI in treatment response evaluation.
        Acad Radiol. 2022; 29: 1065-1084
        • Vorobiev V
        • Adriouach S
        • Crowe LA
        • et al.
        Vascular-targeted micelles as a specific MRI contrast agent for molecular imaging of fibrin clots and cancer cells.
        Eur J Pharm Biopharm. 2021; 158: 347-358
        • Zhang P
        • Wang Z
        • Wang Y
        • et al.
        An MRI contrast agent based on a zwitterionic metal-chelating polymer for hepatorenal angiography and tumor imaging.
        J Mater Chem B. 2020; 8: 6956-6963
        • Sourbron SP
        • Buckley DL
        Classic models for dynamic contrast-enhanced MRI.
        NMR Biomed. 2013; 26: 1004-1027
        • Mills SJ
        • Soh C
        • Rose CJ
        • et al.
        Candidate biomarkers of extravascular extracellular space: a direct comparison of apparent diffusion coefficient and dynamic contrast-enhanced MR imaging–derived measurement of the volume of the extravascular extracellular space in glioblastoma multiforme.
        AJNR Am J Neuroradiol. 2010; 31: 549-553
        • Miller JC
        • Pien HH
        • Sahani D
        • et al.
        Imaging angiogenesis: applications and potential for drug development.
        J Natl Cancer Inst. 2005; 87: 172-187
        • Noebauer-Huhmann IM
        • Amann G
        • Krssak M
        • et al.
        Use of diagnostic dynamic contrast-enhanced (DCE)-MRI for targeting of soft tissue tumour biopsies at 3T: preliminary results.
        Eur Radiol. 2015; 25: 2041-2048
        • Zhang N
        • Zhang L
        • Qiu B
        • et al.
        Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas.
        J Magn Reson Imaging. 2012; 36: 355-363
        • Tofts PS
        Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.
        J Magn Reson Imaging. 1997; 7: 91-101
        • Xu T
        • Zhang L
        • Xu H
        • et al.
        Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basis.
        Oncotarget. 2017; 8: 114360-114370
        • Ma XZ
        • Lv K
        • Sheng JL
        • et al.
        Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
        Oncol Lett. 2019; 17: 3077-3084
        • Etchebehere EC
        • Hobbs BP
        • Milton DR
        • et al.
        Assessing the role of 18F-FDG PET and 18F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.
        Eur J Nucl Med Mol Imaging. 2016; 43: 860-870
        • Katal S
        • Gholamrezanezhad A
        • Kessler M
        • et al.
        PET in the diagnostic management of soft tissue sarcomas of musculoskeletal origin.
        PET Clin. 2018; 13: 609-621
        • Crombé A
        • Fadli D
        • Italiano A
        • et al.
        Systematic review of sarcomas radiomics studies: bridging the gap between concepts and clinical applications?.
        Eur J Radiol. 2020; 132109283
        • Wang H
        • Zhang J
        • Bao S
        • et al.
        Preoperative MRI-based radiomic machine-learning nomogram may accurately distinguish between benign and malignant soft-tissue lesions: A two-center Study.
        J Magn Reson Imaging. 2020; 52: 873-882
        • Malinauskaite I
        • Hofmeister J
        • Burgermeister S
        • et al.
        Radiomics and machine learning differentiate soft-tissue lipoma and liposarcoma better than musculoskeletal radiologists.
        Sarcoma. 2020; 7163453
        • Yan R
        • Hao D
        • Li J
        • et al.
        Magnetic resonance imaging-based radiomics nomogram for prediction of the histopathological grade of soft tissue sarcomas: a two-center study.
        J Magn Reson Imaging. 2021; 53: 1683-1696
        • Corino VDA
        • Montin E
        • Messina A
        • et al.
        Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions.
        J Magn Reson Imaging. 2018; 47: 829-840
        • Zhang Y
        • Zhu Y
        • Shi X
        • et al.
        Soft tissue sarcomas: preoperative predictive histopathological grading based on radiomics of MRI.
        Acad Radiol. 2019; 26: 1262-1268
        • Spraker MB
        • Wootton LS
        • Hippe DS
        • et al.
        MRI radiomic features are independently associated with overall survival in soft tissue sarcoma.
        Adv Radiat Oncol. 2019; 4: 413-421
        • Gitto S
        • Cuocolo R
        • Albano D
        • et al.
        CT and MRI radiomics of bone and soft-tissue sarcomas: a systematic review of reproducibility and validation strategies.
        Insights Imaging. 2021; 12: 68